Dr Puay Hoon Tan has active interests in breast, urologic and renal pathology, and was a Volume Editor of the 2012 (4th series) WHO Classification of Tumours of the Breast. She is a Standing Editorial Board Member for the 5th series of the WHO Classification of Tumours, IARC, Lyon, and is also an expert member for the Breast volume in this latest series. She sits on the Editorial Boards of Modern Pathology, Breast Cancer Research, Pathology, Seminars in Diagnostic Pathology. She is Associate Editor of Histopathology and the Singapore Medical Journal. Apart from a busy service largely focused on subspecialty surgical signouts, she and her collaborators are recipients of several research grants related to translational studies of breast and prostate cancer. She is author of more than 400 publications, and participates regularly in regional and international meetings.

Dr Tira Tan’s research interest is in the study of breast cancer and geriatric oncology. In particular, her focus is on triple negative breast cancer and the conduct of early phase clinical trials. Her academic training and clinical experience has provided her with a broad and solid foundation in medical oncology. Through her training, she has actively participated in research. In the field of geriatric oncology, her abstract on Malnutrition in Elderly Asian Cancer Patients submitted to the American Society of Oncology meeting in 2013 was award with a merit award. Following the completion of her training in October 2015, she joined the Breast team as well as the Phase 1 unit where she actively recruits and follow up on patients in several clinical trials for which she is a co-investigator. She has conceptualized and written several investigator-initiated protocols one of which has started actively recruiting patients.  

Dr Lim graduated from the Yong Loo Lin School of Medicine, National University Singapore in 2007, and commenced her basic specialist training in NUH. This phase of training, which saw her conferred the Membership of the Royal College of Physicians (United Kingdom) in Internal Medicine in 2010, culminated in her being appointed as the Chief Resident of the Internal Medicine Residency Program. She subsequently pursued a year of research training under Professor Daniel Tenen and Dr Li Chai at Beth Israel Deaconess Medical Centre / Brigham and Women Hospital, Harvard Medical School, Boston. Upon returning to Singapore, she completed her advanced specialist training in medical oncology at the National University Cancer Institute, Singapore, where she was appointed as the Senior Chief Resident of Medical Oncology and was admitted as a Fellow of the Academy of Medicine, Singapore (Medical Oncology) in 2015.

Dr Lim has a keen interest in translational research involving novel anti-tumour therapies including molecular targeted agents and immunotherapies, and the application of emerging predictive and pharmacodynamic biomarkers.